REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus Oncology, Inc. (CHRS) on Monday reported a loss of $39.3 million in its third quarter. On a per-share basis, the Redwood City, California-based company said it had a loss of 25 cents. The results missed Wall Street expectations. The average estimate of three analysts...